The Prevalence of Helicobacter pylori Infection in Patients with Chronic Kidney Disease Undergoing Hemodialysis

1. Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: A review. JAMA 2019; 322(13):1294–304. ChenTK KnicelyDH GramsME Chronic kidney disease diagnosis and management: A review JAMA 2019 322 13 1294 304 Search in Google Scholar

2. Neuen BL, Chadban SJ, Demaio AR, Johnson DW, Perkovic V. Chronic kidney disease and the global NCDs agenda. BMJ Glob Health. 2017; 2(2): e000380. NeuenBL ChadbanSJ DemaioAR JohnsonDW PerkovicV Chronic kidney disease and the global NCDs agenda BMJ Glob Health. 2017 2 2 e000380 Search in Google Scholar

3. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2020; 395: 709–33. GBD Chronic Kidney Disease Collaboration Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Lancet 2020 395 709 33 Search in Google Scholar

4. Bello AK, Alrukhaimi M, Ashuntantang GE, Basnet S, Rotter RC, Douthat WG, et al. Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action. Kidney Int Suppl 2017; 7(2): 122–9. BelloAK AlrukhaimiM AshuntantangGE BasnetS RotterRC DouthatWG Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action Kidney Int Suppl 2017 7 2 122 9 Search in Google Scholar

5. Kızıltaş Ş, Şahin S. Upper gastrointestinal disorders among dialysis patients. ACU Sağlık Bil Derg 2019; 10(2):135–41. KızıltaşŞ ŞahinS Upper gastrointestinal disorders among dialysis patients ACU Sağlık Bil Derg 2019 10 2 135 41 Search in Google Scholar

6. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada J-R, et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130(5): 1466–79. TackJ TalleyNJ CamilleriM HoltmannG HuP MalageladaJ-R Functional gastroduodenal disorders Gastroenterology 2006 130 5 1466 79 Search in Google Scholar

7. Ariffin NFM, Naing L, Pisharam J, Khalil MAM, Tamin N, Chong VH, et al. Appetite and gastrointestinal symptoms in end stage renal disease patients. J Clin Exp Nephrol 2016; 1(2): 1–6. AriffinNFM NaingL PisharamJ KhalilMAM TaminN ChongVH Appetite and gastrointestinal symptoms in end stage renal disease patients J Clin Exp Nephrol 2016 1 2 1 6 Search in Google Scholar

8. Lisowska-Myjak B: Uremic toxins and their effects on multiple organ systems. Nephron Clin Pract 2014; 128: 303–11. Lisowska-MyjakB Uremic toxins and their effects on multiple organ systems Nephron Clin Pract 2014 128 303 11 Search in Google Scholar

9. Broberg B, Madsen JL, Fuglsang S, Holst JJ, Christensen KB, Rydahl C, et al. Gastrointestinal motility in patients with end-stage renal disease on chronic hemodialysis. Neurogastroenterol Motil 2019; 31(4): e13554. BrobergB MadsenJL FuglsangS HolstJJ ChristensenKB RydahlC Gastrointestinal motility in patients with end-stage renal disease on chronic hemodialysis Neurogastroenterol Motil 2019 31 4 e13554 Search in Google Scholar

10. Scarpioni R, Ricardi M, Albertazzi V, De Amicis S, Rastelli F, and Zerbini L. Dialysis-related amyloidosis: challenges and solutions. Int J Nephrol Renovasc Dis. 2016; 9: 319–28. ScarpioniR RicardiM AlbertazziV De AmicisS RastelliF ZerbiniL Dialysis-related amyloidosis: challenges and solutions Int J Nephrol Renovasc Dis. 2016 9 319 28 Search in Google Scholar

11. Turshudzhyan A, Inyangetor D. Uremic and post-transplant gastropathy in patients with chronic kidney disease and end-stage renal disease. Cureus 2020; 21; 12(9): e10578. TurshudzhyanA InyangetorD Uremic and post-transplant gastropathy in patients with chronic kidney disease and end-stage renal disease Cureus 2020 21 12 9 e10578 Search in Google Scholar

12. Sugimoto M, Yasuda H, Andoh A. Nutrition status and Helicobacter pylori infection in patients receiving hemodialysis. World J Gastroenterol 2018; 24(15): 1591–600. SugimotoM YasudaH AndohA Nutrition status and Helicobacter pylori infection in patients receiving hemodialysis World J Gastroenterol 2018 24 15 1591 600 Search in Google Scholar

13. Khedmat H, Ahmadzad-Asl M, Amini M, Lessan-Pezeshki M, Einollahi B, Pourfarziani V, et al. Gastro-duodenal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients. Transplant Proc 2007; 39(4): 1003–7. KhedmatH Ahmadzad-AslM AminiM Lessan-PezeshkiM EinollahiB PourfarzianiV Gastro-duodenal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients Transplant Proc 2007 39 4 1003 7 Search in Google Scholar

14. Ji Yong Ahn. Prevalence of Helicobacter pylori infection in patients with chronic kidney disease. Gut Liver 2019; 13(6): 585–6. AhnJi Yong Prevalence of Helicobacter pylori infection in patients with chronic kidney disease Gut Liver 2019 13 6 585 6 Search in Google Scholar

15. Abdulrahman IS, Al-Mueilo SH, Ismail MH, Yasawy MI, Al-Qahtani FN, Al-Qorain AA. Does helicobacter pylori infection in chronic renal failure increase the risk of gastroduodenal lesions? A prospective study. Saudi J gastroenterol 2004; 10(2): 78–85. AbdulrahmanIS Al-MueiloSH IsmailMH YasawyMI Al-QahtaniFN Al-QorainAA Does helicobacter pylori infection in chronic renal failure increase the risk of gastroduodenal lesions? A prospective study Saudi J gastroenterol 2004 10 2 78 85 Search in Google Scholar

16. Usta M, Ersoy A, Ayar Y, Ocakoğlu G, Yuzbasioglu B, Erdem ED, Erdogan O. Comparison of endoscopic and pathological findings of the upper gastrointestinal tract in transplant candidate patients undergoing hemodialysis or peritoneal dialysis treatment: a review of literature. BMC Nephrol 2020; 21:444–52. UstaM ErsoyA AyarY OcakoğluG YuzbasiogluB ErdemED ErdoganO Comparison of endoscopic and pathological findings of the upper gastrointestinal tract in transplant candidate patients undergoing hemodialysis or peritoneal dialysis treatment: a review of literature BMC Nephrol 2020 21 444 52 Search in Google Scholar

17. Ponticelli C, Passerini P. Gastrointestinal complications in renal transplant recipients. Transpl Int 2005;18: 643–50. PonticelliC PasseriniP Gastrointestinal complications in renal transplant recipients Transpl Int 2005 18 643 50 Search in Google Scholar

18. Santos PR, Monteiro DL, de Paula PH, Neto VL, Monte Coelho ML, Arcanjo CC, et al. Volaemic status and dyspepsia in end-stage renal disease patients. Nephrology (Carlton) 2015; 20: 519–22. SantosPR MonteiroDL de PaulaPH NetoVL Monte CoelhoML ArcanjoCC Volaemic status and dyspepsia in end-stage renal disease patients Nephrology (Carlton) 2015 20 519 22 Search in Google Scholar

19. Drossman DA, Dumitrascu DL. Rome III: New standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis 2006; 15(3): 237–41. DrossmanDA DumitrascuDL Rome III: New standard for functional gastrointestinal disorders J Gastrointestin Liver Dis 2006 15 3 237 41 Search in Google Scholar

20. Sugimoto M, Sakai K, Kita M, Imanishi J, Yamaoka Y. Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int 2009; 75: 96–103. SugimotoM SakaiK KitaM ImanishiJ YamaokaY Prevalence of Helicobacter pylori infection in long-term hemodialysis patients Kidney Int 2009 75 96 103 Search in Google Scholar

21. Chang WC, Jo Y-I, Park H-S, Jegal J, Park J-H, Lee J-H, et al. Helicobacter pylori eradication with a 7-day low-dose triple therapy in hemodialysis patient. Clin Exp Nephrol 2010; 14: 469–73. ChangWC JoY-I ParkH-S JegalJ ParkJ-H LeeJ-H Helicobacter pylori eradication with a 7-day low-dose triple therapy in hemodialysis patient Clin Exp Nephrol 2010 14 469 73 Search in Google Scholar

22. Kaneko H, Konagaya T, Kusugami K. Helicobacter pylori and gut hormones. J Gastroenterol 2002; 37(2): 77–86. KanekoH KonagayaT KusugamiK Helicobacter pylori and gut hormones J Gastroenterol 2002 37 2 77 86 Search in Google Scholar

23. Junior, LDS, Santos PR, dos Santos AA, Henrique M, de Souza LP. Dyspepsia and gastric emptying in end-stage renal disease patients on hemodialysis. BMC Nephrol 2013; 14: 275. JuniorLDS SantosPR dos SantosAA HenriqueM de SouzaLP Dyspepsia and gastric emptying in end-stage renal disease patients on hemodialysis BMC Nephrol 2013 14 275 Search in Google Scholar

24. Huang Y, Wang Q, Cheng D, Xu W, and Lu N. Adhesion and invasion of gastric mucosa epithelial cells by Helicobacter pylori. Front Cell Infect Microbiol 2016; 6:159. HuangY WangQ ChengD XuW LuN Adhesion and invasion of gastric mucosa epithelial cells by Helicobacter pylori Front Cell Infect Microbiol 2016 6 159 Search in Google Scholar

25. Aydemir S, Ozdemir BH, Gurg G, Dogan I, Yilmaz U, Boyacioglu S. Effects of Helicobacter pylori infection on gastric epithelial cell kinetics in patients with chronic renal failure. World J Gastroenterol 2005; 11(45): 7183–7. AydemirS OzdemirBH GurgG DoganI YilmazU BoyaciogluS Effects of Helicobacter pylori infection on gastric epithelial cell kinetics in patients with chronic renal failure World J Gastroenterol 2005 11 45 7183 7 Search in Google Scholar

26. Wijarnpreecha K, Thongprayoon C, Nissaisorakarn P, Lekuthai N, Jaruvongvanich V, Nakkala K, et al. Association betwwen Helicobacter pylori and end-stage renal disease: A meta-analysis. World J Gastroenterol 2017; 23(8): 1497–506. WijarnpreechaK ThongprayoonC NissaisorakarnP LekuthaiN JaruvongvanichV NakkalaK Association betwwen Helicobacter pylori and end-stage renal disease: A meta-analysis World J Gastroenterol 2017 23 8 1497 506 Search in Google Scholar

27. Nakajima F, Sakaguchi M, Oka H, Kawase Y, Shibahara N, Inoue T, et al. Prevalence of Helicobacter pylori antibodies in long-term dialysis patients. Nephrology (Carlton) 2004; 9: 73–6. NakajimaF SakaguchiM OkaH KawaseY ShibaharaN InoueT Prevalence of Helicobacter pylori antibodies in long-term dialysis patients Nephrology (Carlton) 2004 9 73 6 Search in Google Scholar

28. Karn W, Charat T, Pichaphon N, et al. Association of Helicobacetr pylori with chronic kidney diseases: a meta-analysis. 2017 Springer, Berlin. KarnW CharatT PichaphonN Association of Helicobacetr pylori with chronic kidney diseases: a meta-analysis 2017 Springer Berlin Search in Google Scholar

29. Li KJ, Chen L. Association between duration of dialysis and Helicobacter pylori infection in dialysis patients: a meta-analysis. Int Urol Nephrol 2019; 51(8): 1361–70. LiKJ ChenL Association between duration of dialysis and Helicobacter pylori infection in dialysis patients: a meta-analysis Int Urol Nephrol 2019 51 8 1361 70 Search in Google Scholar

30. Nakajima F, Sakaguchi M, Amemoto K, Oka H, Kubo M, Shibahara N, et al. Helicobacter pylori in patients receiving long-term dialysis. Am J Nephrol 2002; 22: 468–72. NakajimaF SakaguchiM AmemotoK OkaH KuboM ShibaharaN Helicobacter pylori in patients receiving long-term dialysis Am J Nephrol 2002 22 468 72 Search in Google Scholar

31. Rasmi Y, Farshid S, Makhdomi K. Effect of duration on hemodialysis on prevalence of Helicobacter pylori infection. Saudi J Kidney Dis Transplant 2012; 23: 489–92. RasmiY FarshidS MakhdomiK Effect of duration on hemodialysis on prevalence of Helicobacter pylori infection Saudi J Kidney Dis Transplant 2012 23 489 92 Search in Google Scholar

32. Itatsu T, Miwa H, Nagahara A, Kubota M, Miyazaki A, Sato N, Hayashida Y. Eradication of Helicobacter pylori in hemodialysis patients. Renal Failure 2007; 29: 97–102. ItatsuT MiwaH NagaharaA KubotaM MiyazakiA SatoN HayashidaY Eradication of Helicobacter pylori in hemodialysis patients Renal Failure 2007 29 97 102 Search in Google Scholar

33. Watanabe H, Hiraishi H, Ishida M, Kazama J, Terano A. Pathophysiology of gastric acid secretion in patients with chronic renal failure: influence of Helicobacter pylori infection. J Intern Med 2003; 254(5): 439–46. WatanabeH HiraishiH IshidaM KazamaJ TeranoA Pathophysiology of gastric acid secretion in patients with chronic renal failure: influence of Helicobacter pylori infection J Intern Med 2003 254 5 439 46 Search in Google Scholar

34. Sahara S, Sugimoto M, Ichikawa H, Kagami T, Sakao Y, Ohashi N, et al. Efficacy of reduced dosage of amoxicillin in an eradication therapy for Helicobacter pylori infection in patients on hemodialysis: A randomized controlled trial. Digestion 2018; 97(2): 163–9. SaharaS SugimotoM IchikawaH KagamiT SakaoY OhashiN Efficacy of reduced dosage of amoxicillin in an eradication therapy for Helicobacter pylori infection in patients on hemodialysis: A randomized controlled trial Digestion 2018 97 2 163 9 Search in Google Scholar